West Pharmaceutical India Packaging Private Ltd, an indirect subsidiary of West Pharmaceutical Services, Inc., Lionville, Pa., USA, is setting up its new compression molding facility in Sri City SEZ near Tada in SPSR Nellore district, AP, India. This facility is West’s first plant in India and will become part of West’s global supply chain for its world-class pharmaceutical packaging components. West plans to file Drug Master Files for the plant with the United States Food and Drug Administration and Heath Canada’s Bureau of Pharmaceutical Sciences.
The 15,300 square meter Phase 1 construction will begin in August 2012 on a metal seal assembly and compression molding facility that will produce metal and elastomeric pharmaceutical components used in primary packaging of injectable medicines manufactured by West’s pharmaceutical and biopharmaceutical customers in India and the wider Asia Pacific region. Commercial production of metal components is expected to begin in the first quarter of 2014. Production of a range of West’s high-quality standard elastomeric components is expected to begin in the first quarter of 2015. The capability to produce ready-to-sterilize components will be available by 2016. The built-up area for the plant and office will eventually reach 37,700 square meters at the completion of Phase 3 in 2023.
West signed a 99-year lease on 72,800 square meters of land in the Sri City Special Economic Zone (SEZ) in June 2012. For West, Sri City offers all the advantages of an SEZ with a metropolitan location and was selected primarily on suitability because of land, availability of utilities, labor suitability, logistics, quality of life and SEZ special factors.
Source: West Pharmaceutical